衛生福利部屏東醫院 化學 ... - pntn.mohw.gov.tw

1 1 .. 3 .. 3 .. 4 .. 5 .. 6 .. 7 .. 7 .. 8 .. 10 .. 15 .. 15 .. 20 .. 22 .. 23 .. 24 .. 25 .. 26 .. 27 .. 29 .. 29 .. 31 .. 31 .. 31 .. 42 .. 42 .. 44 .. 49 .. 49 .. 49 .. 49 .. 49 1 1.

2 2. 3. 4. 5. 6. 7. 1. 2. 3. 4. 5. 6. 7. 1. 96 98 12 10 101 03 15 2 2. 94 11-13 3. ~23 & 3 Cell cycle G1 S G2 M G0 1.

3 2. 3. RNA DNA G0 RNA (89) P3 G2 S M G1 G1 R A 4 1. Alkylating agents G1 S DNA RNA DNA 2. Antimetabolites S 3. Antibiotics G1 G2 M DNA RNA 4. Plant alkaloids Mitotic Inhibitors G1 S 5. Immunodulators DNA RNA Pro 6.

4 Endocrine therapy Hormones Antagonists DNA RNA Pro 7. Miscellanous DNA RNA Pro combination chemotherapy 1. Induction chemotherapy complete remission Leukemia AML I3A7 2. consolidation chemotherapy Leukemia AML I2A5 3. Maintenance chemotherapy Leukemia AML Low dose Ara-c 4. Intensification chemotherapy Leukemia AML High dose Ara-c 5.

5 Adjuvant chemotherapy 5 Breast CA 6. Neoadjuvant chemotherapy NPC CCRT 7. Palliative chemotherapy 8. Salvage chemotherapy 1. CVC Port-V cath PICC IV PUSH IV DRIP IV KEEP 2.

6 MTX UFTR Etoposide Hydrea Thalidomide Tamoxifen Glivec 3. Ara-c MTX Z 2~ 4. 6 1 MTX 5-FU Mitomycin-C BCNU Epirubicin Cispltin Port-A cath 2 Epirubicin 5. 1 2 2 CSF BBB MTX Ara-c 3 2 OK-432 Bleomycin Ara-c 4 1~2 Epirubicin Mitomycin-C Bleomycin 1.

7 89 1-41 2. 89 157-172 3. 89 1-7 7 1. 1 2 3 4 5 CVC cath PICC cath IVmedicut PORT PORT 8 2.

8 1 2 BSA M2 3 CBC DC ANC 4 5 6 7 3. 1 89 157-172 2 ~23 & 1.

9 1 2 3 24 9 1 9:30AM&2:30PM 10:30AM 15:00PM 10:30 15:00 15:00 10 1.

10 1. 2. 3. 4. 1. 2. 3. 4. 1. 2. 3. - 1. IC 2. 11 3. 4.